Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Breast Cancer
Sep 22, 2024, 17:46 |
Blog
Francisco J. Esteva: KEYNOTE-522 Trial Shows Pembrolizumab Boosts Survival in Triple-Negative Breast Cancer
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital, posted the…
Sep 22, 2024, 17:23 |
Insight
Jody Wallace: Integration and Outcomes of Multigene Panel Testing for Newly Diagnosed Breast Cancer Patients
Jody Wallace shared a post on LinkedIn: "Exciting News! Our manuscript, 'Integration and Outcomes of…
Sep 21, 2024, 13:07 |
Blog
Olubukola Ayodele about HER2 low breast cancer
Olubukola Ayodele shared a post on LinkedIn: ''Let's talk about HER2 low breast cancer. The…
Sep 21, 2024, 09:35 |
Blog
Elisa Agostinetto: Characteristics and clinical outcomes of breast cancer
Elisa Agostinetto shared a post on X, about recent paper published in ESMO Open: Characteristics…
Sep 20, 2024, 13:57 |
Blog
Adrian Lee: Addressing breast cancer data underutilization with Estrogene2.0
Adrian Lee, Director, Insitute for Precison Medicine at UPMC, posted the following on LinkedIn: “When researchers…
Sep 20, 2024, 13:00 |
Blog
The 1st webinar of the ’24-‘25 EMBRACE Metastatic Breast Cancer Forum Series - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on X: ''Join Nancy Lin, and Sara Tolaney, via Zoom for…
Sep 19, 2024, 16:32 |
Blog
Monika Pansari: Breast Cancer in Younger Women: The Urgent Need for Awareness and Early Detection
Monika Pansari, Senior Consultant Surgical Oncologist at Fortis Hospital, Bangalore, shared a post on LinkedIn:…
Sep 19, 2024, 14:24 |
Insight
Elisa Agostinetto: FDA has approved ribociclib with an AI for the adjuvant treatment of HR+/HER2-negative breast cancer
Elisa Agostinetto shared a post on X: “Novartis today announced that the FDA has approved…
Sep 19, 2024, 12:03 |
Insight
Trastuzumab deruxtecan in HER2-positive advanced Breast Cancer
Dana-Farber’s Breast Oncology Center shared on X: “Hot off the Press! Trastuzumab deruxtecan in HER2-positive…
Sep 19, 2024, 02:22 |
Blog
Big EORTC24 webinar on breast cancer research milestones - EORTC
EORTC – European Organisation for Research and Treatment of Cancer posted the following on LinkedIn:…
3
4
5
6
7
All:
2516
Posts:
41 - 50
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities
ASTRO 24: 15 Posts Not to Miss From Day 2
Julia Louis-Dreyfus and Breast Cancer: How She Went Against, How She Survived, and More
ASTRO24: 20 Posts Not To Miss From Day 1
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube